Can platelet aggregometry be standardized?

Platelets

Volumn 16, Issue 3-4, 2005, Pages 151-158

  Breddin, Hans Klaus ^a  

^a International Institute of Thrombosis and Vascular Diseases   (Germany)

Author keywords

Aggregometry; Platelets; Standardization

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ANTICOAGULANT AGENT; ARACHIDONIC ACID; CITRATE TRISODIUM; CLOPIDOGREL; COLLAGEN; FIBRINOGEN RECEPTOR ANTAGONIST; LEPIRUDIN; PROSTAGLANDIN DERIVATIVE; RISTOCETIN; SEROTONIN; THIENO[2,3 B]PYRIDINE DERIVATIVE; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOXANE A2;

ARTICLE; AWARENESS; BLOOD SAMPLING; CALIBRATION; CLINICAL RESEARCH; CONTROLLED STUDY; HEMOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; OPTICAL DENSITY; PLATELET AGGREGOMETRY; PRIORITY JOURNAL; RELIABILITY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; STANDARDIZATION; TEMPERATURE MEASUREMENT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

BLOOD PLATELETS; BLOOD SPECIMEN COLLECTION; GUIDELINES; HUMANS; INDICATORS AND REAGENTS; NEPHELOMETRY AND TURBIDIMETRY; PLATELET AGGREGATION; REFERENCE STANDARDS;

EID: 21344442173     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537100400020161     Document Type: Article

References (26)

1. Breddin HK. Wertigkeit von Plättchenfunktionstests. VASA 2003;3(32):123-129.
2. Born GVR. Quantitative investigations into the aggregation of blood platelets. J Physiol 1962;162:67-68.
3. Breddin K, Grün H, Ziemen M, Bauer M, Krzywanek HJ. Factors influencing spontaneous and induced platelet aggregation. Studies with a new aggregometer. In: Ulutin O, editor. Proceedings of the International Symposium on Blood Platelets. Excerpta Medica Amsterdam; 1976. pp 302-314.
4. Ts'Ao C-H, Lo R, Raymond J. Critical importance of citrate-blood ratio in platelet aggregation studies. Am J Clin Path 1976;65:518-522.
5. Basic-Micic M, Rauschenbach C, Demgen G, Krupinski K, Dechent C, Roman C, Breddin HK. Hirudin als Antikoagulans zur Untersuchung der Thrombozytenfunktion. Hämostaseologie 1991;11:114-121.
6. Reuter H, Podolsak B, Hagen I, Linker H, Ströder J, Gross R. Investigations on the time dependence of platelet functions I. General methodical investigations. Thromb Res 1973;3:307-325.
7. Han P, Ardlie NG. The influence of pH, temperature, and calcium on platelet aggregation: maintenance of environmental pH and platelet function for in vitro studies in plasma stored at 37°C. Br J Haemal 1974;26:373-389.
8. Fyfe T, Hamilton E. Effect of variations of the interval between venepuncture and measurement of platelet adhesiveness by the payling wright method. Lancet 1967;542-543.
9. Rossi EC, Louis G. A time-dependent increase in the responsiveness of platelet-rich plasma to epinephrine. J Lab Clin 1975;85:300-306.
10. Praga CA, Pogliani KM. Effect of temperature on ADP-induced platelet aggregation. Its significance in studying anti-aggregating drugs. Thrombos Diathes Haemorrh 1973; 29:183-189.
11. Warlow C, Corina A, Ogston D, Douglas AS. The relationship between platelet aggregation and time interval after venepuncture. Thrombos Diathes Haemorrh 1974;31:133-141.
12. Breddin K, Ziemen M, Bauer O, Herrmann W, Schaudinn L, Schlosser U, Winterhagen A, Krzywanek HJ. Time and temperature dependent changes of ADP- and collagen-induced and 'spontaneous' aggregation. Thromb Res 1980;19:621-638.
13. Kitek A, Breddin K. Optical density variations and microscopic observations in die evaluation of platelet shape change and microaggregate formation. Thrombos Haemostas 1980;44:154-158.
14. Rogers AB. The effect of pH on human platelet aggregation induced by epinephrine and ADP. Proc Soc Exp Biol Med 1972;139:1100-1103.
15. Mani H, Linnemann B, Kirchmayr K, Kläffling C, Erbe M, Lindhoff-Last E. Using native or platelet count adjusted platelet-rich plasma for platelet aggregation tests. VASA 2004;33(Suppl. 65):20, abstract P006.
16. O'Brien JR. Variability in the aggregation of human platelets by adrenaline. Nature 1964;202:1188-1190.
17. Coller BS, Gralnick HR, Burt S. The effect of stir bar size and shape on quantitative platelet aggregation. Thromb Res 1976;8:121-129.
18. Cardinal DL, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behaviour. J Pharmacol Meth 1980;3:135-158.
19. Mascelli MA, Worley S, Verlabo NJ, Lance ET, Mack S, Schaible T, Weisman HE, Jordan RE. Rapid assessment of platelet function with a modified whole blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GPIIb/IIIa therapy. Circulation 1997;96: 3860-3866.
20. Krzywanek HJ. Klinische Bedeutung der Thrombozytenfunktionsdiagnostik. Stuttgart, New York: Fischer; 1987. pp 22-33.
21. Breddin K. Klinische und experimentelle Untersuchungen über die Thrombozytenaggregation bei Gefäßerkrankungen. D Med Wschr 1968;93:1555-1565.
22. Breddin HK, Grun H, Krzywanek HJ, Schremmer P. On the Measurement of spontaneous platelet aggregation. The platelet aggregation test III. Methods and first clinical results. Thrombos Haemostas 1976;35:302-314.
23. Breddin HK, Krzywanek HJ, Althoff P, Kirchmaier CM, Rosak C, Schepping M, Weichen W, Ziemen M, Schöffling K, Überla K. Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Internat Angiol 1986; 5:181-195.
24. Breddin HK, Lippold R, Bittner M, Kirchmaier CM, Krzywanek HJ, Michaelis J. Spontaneous platelet aggregation as a predictive risk factor on vascular occlusions in healthy volunteers? Results of the HAPARG Study. Haemostatic parameters as risk factors in healthy volunteers. Atherosclerosis 1999;144:211-219.
25. Syrbe G, Redlich H, Weidlich B, Ludwig J, Kopitzsch S, Göckeritz A, Herzog K. Individual dosing of ASA prophylaxis by controlling platelet aggregation. Clin Appl Thromb/Haemost 2001;7(3):209-213.
26. Harder S, Kirchmaier CM, Krzywanek HJ, Westrup D, Bae JW, Breddin HK. Pharmacokinetics and pharmacodynamic effects of a new antibody glycoprotein IIb/IIIa inhibitor (YM337) in healthy subjects. Circulation 1999;100: 1175-1181.